Skip to main content
SpringerLink
Log in

Geschwollen, gerötet, überwärmt, aber nicht schmerzhaft

Übersehen Sie den Charcot-Fuß nicht!

A specific characteristic of the diabetic foot — the diabetic-neuropathic osteoarthropathy

  • FORTBILDUNG_SEMINAR
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Der Charcot-Fuß ist eine potenziell verheerende Komplikation des Diabetes mellitus, die im ungünstigen Verlauf zur Amputation führen kann. Daher ist es wichtig, dass Sie bei entsprechender Klinik (Schwellung, Rötung, Überwärmung) frühzeitig daran denken. Bei den Betroffenen selbst ist das Krankheitsempfinden bei dem nicht schmerzhaften und wenig bedrohlich erscheinenden lokalen Befund oft nur mäßig ausgeprägt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Sanders LJ. The Charcot foot: historical perspective 1827-2003. Diabetes/metabolism research and reviews. 2004;20 Suppl 1:S4–8.

    Article  PubMed  Google Scholar 

  2. Jeffcoate WJ. Charcot neuro-osteoarthropathy. Diabetes/metabolism research and reviews. 2008;24 Suppl 1:S62–5.

    Article  PubMed  Google Scholar 

  3. Zimny S. Diagnostik und Therapie bei diabetisch neuropatischer Osteoarthropathie in: Eckardt A., Lobmann R.. der diabetische Fuß Springer Verlag Heidelberg 2005

  4. Papanas N, Maltezos E. Etiology, pathophysiology and classifications of the diabetic Charcot foot. Diabetic foot & ankle. 2013;4.

  5. Varma AK. Charcot neuroarthropathy of the foot and ankle: a review. The Journal of foot and ankle surgery: official publication of the American College of Foot and Ankle Surgeons. 2013;52(6):740–9.

    Article  Google Scholar 

  6. Donegan R, Sumpio B, Blume PA. Charcot foot and ankle with osteomyelitis. Diabetic foot & ankle. 2013;4.

  7. Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L, Wukich DK, Uccioli L. The Charcot foot in diabetes.Diabetes Care. 2011;34(9):2123–9.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Lobmann R., Achwerdov O., Brunk-Loch S., Engels G., Trocha A., Groene C., Kersken J. for the quality management representatives of the working group diabetic foot of the German Diabetes Society The diabetic foot in Germany 2005–2012: Analysis of quality in specialized diabetic foot care centers Wound Medicine 4 (2014) 27–29

    Google Scholar 

  9. Game F, Jeffcoate W. The charcot foot: neuropathic osteoarthropathy. Advances in skin & wound care. 2013;26(9):421–8; quiz 9-30.

    Article  Google Scholar 

  10. Gouveri E, Papanas N. Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice. World journal of diabetes. 2011;2(5):59–65.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet. 2005;366(9502):2058–61.

    Article  CAS  PubMed  Google Scholar 

  12. Mabilleau G, Petrova NL, Edmonds ME, Sabokbar A. Increased osteoclastic activity in acute Charcot’s osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.Diabetologia. 2008;51(6):1035–40.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Larson SA, Burns PR. The pathogenesis of Charcot neuroarthropathy: current concepts. Diabetic foot & ankle. 2012;3.

  14. Ndip A, Williams A, Jude EB, Serracino-Inglott F, Richardson S, Smyth JV, et al. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes. 2011;60(8):2187–96.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Chantelau EA, Richter A. The acute diabetic Charcot foot managed on the basis of magnetic resonance imaging—a review of 71 cases. Swiss medical weekly. 2013;143:w13831.

    PubMed  Google Scholar 

  16. Ergen FB, Sanverdi SE, Oznur A. Charcot foot in diabetes and an update on imaging. Diabetic foot & ankle. 2013;4.

  17. Guven MF, Karabiber A, Kaynak G, Ogut T. Conservative and surgical treatment of the chronic Charcot foot and ankle. Diabetic foot & ankle. 2013;4.

  18. Jostel A, Jude EB. Medical treatment of Charcot neuroosteoarthropathy. Clinics in podiatric medicine and surgery. 2008;25(1):63–9, vi-vii.

    Article  PubMed  Google Scholar 

  19. Waldecker U., Eckhardt A. Operative Maßnahmen in: Eckardt A., Lobmann R.. der diabetische Fuß Springer Verlag Heidelberg 2005

Download references

Author information

Authors and Affiliations

  1. Klinik für Endokrinologie, Diabetologie und Geriatrie, Klinikum Stuttgart — Bad Cannstatt, Prießnitzweg 24, D-70374, Stuttgart, Deutschland

    Ralf Lobmann (Ärztl. Direktor)

Authors
  1. Ralf Lobmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ralf Lobmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lobmann, R. Übersehen Sie den Charcot-Fuß nicht!. MMW - Fortschritte der Medizin 157, 61–65 (2015). https://doi.org/10.1007/s15006-015-3356-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-015-3356-z

Keywords

Search

Navigation